Abstract:Despite multimodal treatment, 90% of patients diagnosed with isocitrate dehydrogenase (IDH) wild-type glioblastoma experience tumour recurrence within 5 years. Poor prognosis is in considerable part attributed to the ability of cancer cells to infiltrate a healthy brain. We hypothesise that metabolic changes underpinning cellular crosstalk between astrocytes and glioblastoma cells isolated from the invasive margin within a physiologically representative in-vitro tumour microenvironment may reveal therapeutic targets to prevent or delay glioblastoma recurrence. This study used advanced analytical techniques to establish baseline metabolomic profiles for eGFP-tagged primary glioblastoma cells isolated from the invasive margin and healthy human cortical astrocytes. Liquid chromatography-mass spectrometry (LC-MS) enabled detailed analysis of biochemical pathways, and Atmospheric Pressure-Matrix Assisted Laser Desorption/Ionisation (AP-MALDI) imaging offered spatial localization of metabolites, critical for mapping their distribution within tumour microenvironments. Metabolites were extracted using a biphasic method (methanol:chloroform:water) for LC-MS analysis, and metabolic profiling was conducted using a ZIC-pHILIC column coupled with a Q-Exactive Orbitrap Mass Spectrometer. Additionally, AP-MALDI imaging facilitated the generation of high-resolution spatial distribution maps of selected metabolites, achieving a resolution of 10 μm. Both multivariate and univariate statistical analyses were applied to identify significant metabolic alterations. Metabolic profiling identified distinct pathways altered in glioblastoma cells compared to astrocytes, including alterations in aspartate, glycine and serine, and lipid metabolism. High-resolution imaging outlined the spatial distribution of metabolites involved in these pathways, revealing regions of metabolic heterogeneity. Furthermore, this methodology facilitated an expanded identification range of essential biomolecules, notably lipids and amino acids, thereby augmenting our understanding of their dynamic functions across diverse cellular contexts. By leveraging the complementary strengths of LC-MS and AP-MALDI imaging, this research enhances our understanding of spatial metabolite distribution in glioblastoma cells isolated from the invasive margin and suggests potential applications in patient tissue, offering a deeper exploration of disease mechanisms.

Machine Learning-based Predictions of Spatial Metabolic Profiles Demonstrate the Impact of Morphology on Astrocytic Energy Metabolism

Mapping Metabolic Changes by Noninvasive, Multiparametric, High-Resolution Imaging Using Endogenous Contrast.

Energy Demand and Metabolite Partitioning in Spatially Lumped and Distributed Models of Neuron-Astrocyte Complex

Toward Modeling Metabolic State from Single-Cell Transcriptomics.

Spatiotemporal Imaging of Cellular Energy Metabolism with Genetically-Encoded Fluorescent Sensors in Brain

Abstract 5498: Multi-modal examination of spatial heterogeneity in the astrocytoma microenvironment

Astrocytic Signatures in Neuronal Activity: A Machine Learning-Based Identification Approach

A spatially distributed model of brain metabolism highlights the role of diffusion in brain energy metabolism

Exploring the spatial effects influencing the EGFR/ERK pathway dynamics with machine learning surrogate models

Mechanistic Description of Spatial Processes Using Integrative Modelling of Noise-Corrupted Imaging Data

Single-nucleus transcriptional profiling uncovers the reprogrammed metabolism of astrocytes in Alzheimer's disease.

In vivo neuropil density from anatomical MRI and machine learning

Prediction of intracellular metabolic states from extracellular metabolomic data

Machine learning approach for recognition and morphological analysis of isolated astrocytes in phase contrast microscopy

Brain metabolic sensing and metabolic signaling at the level of an astrocyte

Multi-modal, Label-free, Optical Mapping of Cellular Metabolic Function and Oxidative Stress in 3D Engineered Brain Tissue Models

Tmet-23. Mass Spectrometry-Based Metabolic Profiling And Imaging Of Astrocyte And Glioblastoma Invasive Margin Cells

Characterization of Energy and Neurotransmitter Metabolism in Cortical Glutamatergic Neurons Derived from Human Induced Pluripotent Stem Cells: A Novel Approach to Study Metabolism in Human Neurons

Astrocytes as Key Regulators of Brain Energy Metabolism: New Therapeutic Perspectives

Computational Modeling of Cardiac Metabolism in Atrial Myocytes.

Metabolic Heterogeneity of Cerebral Cortical and Cerebellar Astrocytes